Form D · Pharmaceuticals
Pharmapotheca A, LLC
Delmar, NY · CIK 0001684726
Offering snapshot reported Sep 2, 2020 · SEC filing
- Reported sold
- $2.5M Offering amount: $2.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Aug 31, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 2, 2020 | Initial | $2,500,000 | No comparison | 4 | SEC filing |
| Jul 13, 2018 | Amendment | $585,000 | $175,000vs Sep 18, 2017 | 13 | SEC filing |
| Sep 18, 2017 | Amendment | $410,000 | $235,000vs Sep 19, 2016 | 10 | SEC filing |
| Sep 19, 2016 | Initial | $175,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-374675
Round closed August 31, 2020.
Source: Form D, filed Sep 2, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas D. Livingston | Executive |
| Harold Meckler | Director, Executive |
| Karl F. Popp | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
45 Preston Road
Delmar, NY, 12054
Delmar, NY, 12054